Track topics on Twitter Track topics that are important to you
Since its founders developed one of the worldĂ˘Â€Â™s first cochlear implants in the 1970s, MED-EL has set new standards in hearing implant technologies, developing and manufacturing technologically advanced hearing solutions for people with varying degrees of hearing loss. MED-EL hearing implant systems, currently used in 96 countries, combine the latest scientific advances, engineering and manufacturing techniques for performance, safety and reliability. MED-EL offers the broadest portfolio of hearing implant systems, including the MAESTRO Cochlear Implant system for those with severe-to-profound sensorineural hearing loss and the unique Vibrant SoundbridgeĂ‚Â®, a middle ear prosthesis for the treatment of moderate to severe sensorineural hearing loss. The fast-growing medical technology company employs more than 1,000 people worldwide, more than 650 of whom are based at the companyĂ˘Â€Â™s headquarters in Innsbruck, where R&D and production are located. For more information, visit www.medel.com or call 888-MED-EL-CI (633-3524).
We have published hundreds of MED-EL Corporation news stories on BioPortfolio along with dozens of MED-EL Corporation Clinical Trials and PubMed Articles about MED-EL Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MED-EL Corporation Companies in our database. You can also find out about relevant MED-EL Corporation Drugs and Medications on this site too.
Latest News Clinical Trials Research Drugs Reports Corporate
Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...